{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:38:18Z","timestamp":1751373498663},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:sec id=\"ab-hoi220053-4\"><jats:title>Importance<\/jats:title><jats:p>The United Network for Organ Sharing (UNOS) evaluates donor risk for acute transmission of HIV, hepatitis B, or hepatitis C based on US Public Health Services (PHS)\u2013specific criteria. However, recent data regarding use and outcomes of those donors with PHS risk criteria among pediatric and adult heart transplant recipients are lacking.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220053-5\"><jats:title>Objective<\/jats:title><jats:p>To compare use and outcomes of graft from donors with PHS risk criteria vs those with a standard-risk donor (SRD) in children vs adults in a contemporary cohort.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220053-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort was a nationwide analysis of heart transplants in the US that used data from the UNOS database. Participants were children (&amp;amp;lt;18 years old) and adults (\u226518 years old) who received a heart transplant from January 1, 2010, to December 31, 2021.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220053-7\"><jats:title>Exposures<\/jats:title><jats:p>UNOS-defined donor risk status.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220053-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Trend analysis compared changes in PHS risk criteria use among children and adults. Patient survival was analyzed using Kaplan-Meier curves with log rank and Cox proportional hazards to compare PHS risk-criteria outcomes vs SRD-criteria outcomes in children and adult heart transplant recipients. Additional analysis was performed among adults who received a PHS\u2013risk criteria graft that was previously declined for pediatric recipients.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220053-9\"><jats:title>Results<\/jats:title><jats:p>Of 5115 pediatric transplant recipients (donor without PHS risk median [IQR] age, 5 [0-13] years and donor with PHS risk median [IQR] age, 8 [0-14] years) and 30\u202f289 adult heart transplant recipients (donor without PHS risk median [IQR] age, 56 [46-63] years and donor with PHS risk median [IQR] age, 57 [47-63] years), PHS risk criteria comprised 8% in children vs 25% in adults. PHS criteria are being increasingly used over the past decade with the proportion of recipients transplanted with PHS risk-criteria donors being approximately 3 times greater among adult recipients than children recipients. Pediatric recipients of a PHS risk-criteria donor had greater pretransplant ventilatory support, whereas adult recipients of a PHS risk-criteria donor had greater pretransplant extracorporeal membrane oxygenation use. Patient survival was similar between pediatric recipients of PHS risk-criteria grafts vs SRD-criteria grafts and slightly higher among adult recipients of PHS risk-criteria grafts vs SRD-criteria grafts. The 1778 adult recipients who received a PHS criteria-risk donor that was previously declined for pediatric recipients had similar patient survival recipients compared with SRD-criteria donors (HR, 0.92; 95% CI, 0.81-1.03; <jats:italic>P<\/jats:italic>\u2009=\u2009.18).<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220053-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In the current era, a 3-fold greater proportion of adult recipients receive a PHS risk-criteria graft compared with children despite similar posttransplant patient survival. The ongoing organ donor shortage underscores the need for consideration of PHS risk criteria where these donors remain underused.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2022.3070","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T15:02:35Z","timestamp":1663772555000},"page":"1121","source":"Crossref","is-referenced-by-count":6,"title":["Association of Donors With US Public Health Service Risk Criteria and Outcomes After Adult vs Pediatric Cardiac Transplant"],"prefix":"10.1001","volume":"7","author":[{"given":"Danielle S.","family":"Burstein","sequence":"first","affiliation":[{"name":"Cardiology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Rossano","sequence":"additional","affiliation":[{"name":"Cardiology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[{"name":"Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly H.","family":"Schlendorf","sequence":"additional","affiliation":[{"name":"Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nhue","family":"Do","sequence":"additional","affiliation":[{"name":"Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Godown","sequence":"additional","affiliation":[{"name":"Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"Cardiology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhide","family":"Maeda","sequence":"additional","affiliation":[{"name":"Cardiac Surgery, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Edelson","sequence":"additional","affiliation":[{"name":"Cardiology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Cardiology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy A.","family":"Mazurek","sequence":"additional","affiliation":[{"name":"Cardiology, Hospital of University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley R.","family":"Scholl","sequence":"additional","affiliation":[{"name":"Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan N.","family":"Menachem","sequence":"additional","affiliation":[{"name":"Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"hoi220053r1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/ajt.v21.s2","article-title":"OPTN\/SRTR 2019 Annual data report: heart.","volume":"21","author":"Colvin","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"hoi220053r2","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.healun.2020.07.008","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics.","volume":"39","author":"Singh","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"hoi220053r3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.healun.2020.07.010","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics.","volume":"39","author":"Khush","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"hoi220053r4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jtcvs.2013.09.018","article-title":"Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list.","volume":"147","author":"Jeewa","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"hoi220053r5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/ajt.2017.17.issue-6","article-title":"Inferior outcomes on the waiting list in low-volume pediatric heart transplant centers.","volume":"17","author":"Rana","year":"2017","journal-title":"Am J Transplant"},{"issue":"4","key":"hoi220053r7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6904a1","article-title":"Assessing solid organ donors and monitoring transplant recipients for human immunodeficiency virus, hepatitis b virus, and hepatitis c virus infection\u2014US public health service guideline, 2020.","volume":"69","author":"Jones","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"hoi220053r8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.healun.2014.06.005","article-title":"Centers for Disease Control \u201chigh-risk\u201d donor status does not significantly affect recipient outcome after heart transplantation in children.","volume":"33","author":"Sahulee","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"hoi220053r9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cardfail.2016.01.008","article-title":"Transplantation of Center for Disease Control \u201chigh-risk\u201d donor hearts does not adversely impact long-term outcomes in adults.","volume":"22","author":"Gaffey","year":"2016","journal-title":"J Card Fail"},{"issue":"12","key":"hoi220053r10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/tri.12835","article-title":"Donor predictors of allograft utilization for pediatric heart transplantation.","volume":"29","author":"Khan","year":"2016","journal-title":"Transpl Int"},{"issue":"5","key":"hoi220053r11","doi-asserted-by":"publisher","DOI":"10.1111\/petr.2019.23.issue-5","article-title":"Variability in donor selection among pediatric heart transplant providers: results from an international survey.","volume":"23","author":"Godown","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"3","key":"hoi220053r12","doi-asserted-by":"publisher","DOI":"10.1111\/petr.v24.3","article-title":"Behavioral economics\u2014a framework for donor organ decision-making in pediatric heart transplantation.","volume":"24","author":"Butler","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"1","key":"hoi220053r13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtcvs.2015.12.062","article-title":"Transplantation of \u201chigh-risk\u201d donor hearts: implications for infection.","volume":"152","author":"Gaffey","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"hoi220053r14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamacardio.2019.4748","article-title":"Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C.","volume":"5","author":"Schlendorf","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"9","key":"hoi220053r15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jamacardio.2020.2696","article-title":"Trends in US heart transplant waitlist activity and volume during the coronavirus disease 2019 (COVID-19) pandemic.","volume":"5","author":"DeFilippis","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"hoi220053r16","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.ijcard.2013.03.003","article-title":"Heart failure admissions in adults with congenital heart disease; risk factors and prognosis.","volume":"168","author":"Zomer","year":"2013","journal-title":"Int J Cardiol"},{"key":"hoi220053r6","unstructured":"US Center for Disease Control and Prevention. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Accessed March 25, 2022. https:\/\/wonder.cdc.gov\/wonder\/prevguid\/m0031670\/m0031670.asp"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2796742\/jamacardiology_burstein_2022_oi_220053_1667925976.87294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:04:31Z","timestamp":1668009871000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2796742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2022.3070","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}